Tower Research Capital LLC (Trc) Avid Bioservices, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,387 shares of CDMO stock, worth $90,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,387
Previous 12,011 38.5%
Holding current value
$90,860
Previous $85,000 1.18%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$6.7 - $12.45 $30,980 - $57,568
-4,624 Reduced 38.5%
7,387 $84,000
Q2 2024

Aug 13, 2024
BUY
$6.34 - $9.28 $64,585 - $94,535
10,187 Added 558.5%
12,011 $85,000
Q1 2024

May 15, 2024
SELL
$5.86 - $8.79 $15,212 - $22,818
-2,596 Reduced 58.73%
1,824 $12,000
Q4 2023

Feb 13, 2024
BUY
$4.64 - $9.56 $4,644 - $9,569
1,001 Added 29.28%
4,420 $28,000
Q3 2023

Nov 14, 2023
SELL
$9.4 - $14.04 $25,286 - $37,767
-2,690 Reduced 44.03%
3,419 $32,000
Q2 2023

Aug 14, 2023
BUY
$12.96 - $20.93 $42,768 - $69,069
3,300 Added 117.48%
6,109 $85,000
Q1 2023

May 09, 2023
SELL
$13.48 - $18.79 $30,950 - $43,141
-2,296 Reduced 44.98%
2,809 $52,000
Q4 2022

Feb 10, 2023
BUY
$12.61 - $18.74 $16,733 - $24,867
1,327 Added 35.12%
5,105 $70,000
Q3 2022

Nov 10, 2022
SELL
$15.33 - $20.36 $132,251 - $175,645
-8,627 Reduced 69.54%
3,778 $72,000
Q2 2022

Aug 15, 2022
BUY
$11.63 - $21.55 $124,836 - $231,317
10,734 Added 642.37%
12,405 $189,000
Q1 2022

May 12, 2022
SELL
$16.63 - $27.73 $82,368 - $137,346
-4,953 Reduced 74.77%
1,671 $34,000
Q4 2021

Feb 14, 2022
SELL
$20.7 - $34.18 $107,660 - $177,770
-5,201 Reduced 43.98%
6,624 $193,000
Q3 2021

Nov 15, 2021
BUY
$19.05 - $28.32 $179,241 - $266,462
9,409 Added 389.45%
11,825 $255,000
Q2 2021

Aug 16, 2021
SELL
$18.93 - $25.65 $47,230 - $63,996
-2,495 Reduced 50.8%
2,416 $62,000
Q1 2021

May 17, 2021
SELL
$11.86 - $21.77 $36,932 - $67,791
-3,114 Reduced 38.8%
4,911 $90,000
Q4 2020

Feb 16, 2021
SELL
$7.25 - $11.76 $381,937 - $619,528
-52,681 Reduced 86.78%
8,025 $92,000
Q3 2020

Nov 16, 2020
BUY
$6.53 - $8.6 $317,436 - $418,063
48,612 Added 401.95%
60,706 $463,000
Q2 2020

Aug 13, 2020
BUY
$4.11 - $6.78 $49,706 - $81,997
12,094 New
12,094 $79,000
Q4 2019

Feb 07, 2020
SELL
$5.01 - $8.16 $26,618 - $43,354
-5,313 Closed
0 $0
Q3 2019

Nov 05, 2019
SELL
$5.07 - $7.08 $567 - $792
-112 Reduced 2.06%
5,313 $29,000
Q2 2019

Aug 13, 2019
SELL
$3.43 - $5.6 $52,362 - $85,489
-15,266 Reduced 73.78%
5,425 $31,000
Q1 2019

May 14, 2019
BUY
$3.56 - $4.82 $70,502 - $95,455
19,804 Added 2232.69%
20,691 $88,000
Q4 2018

Feb 14, 2019
BUY
$4.04 - $6.75 $3,583 - $5,987
887 New
887 $4,000

Others Institutions Holding CDMO

# of Institutions
183
Shares Held
67.8M
Call Options Held
89.9K
Put Options Held
118K
View Full List

About Avid Bioservices, Inc.

CDMO Quotes by TradingView
  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $765M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email